Rights and permissions
About this article
Cite this article
Gemtuzumab ozogamicin active in relapsed/refractory paediatric AML. Inpharma Wkly. 1396, 16 (2003). https://doi.org/10.2165/00128413-200313960-00036
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313960-00036